A brain Na+, K+-ATPase inhibitor (endobain E) enhances norepinephrine release in rat hypothalamus

Neuroscience

Volumn 90, Issue 2, 1999, Pages 573-579

  Vatta, M ^a   Pena C ^b   Fernández, B ^a   Rodriguez De Lores Arnaiz G ^b  

^a Catedra Fisiol Fisiopatol P   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Endobain; Hypothalamus; K+ ATPase; Na+; Norepinephrine release; Ouabain; Ouabain like factor

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HYPOTHALAMUS; MALE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

EID: 0345320475     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00421-7     Document Type: Article

References (45)

1. Albers R. W., Siegel G. J. and Stahl W. (1994) Membrane transport. In Basic Neurochemistry (eds Siegel G. J., Agranoff B. W., Albers R. W. and Molinoff P. B.), 5th edn, pp. 49-74. Raven, New York.
2. +-ATPase is increased in astrocytes of rat hippocampus after treatment with kainic acid. Neurochem. Int. 31:1997;549-556.
3. +ATPase modifiers on high-affinity ouabain binding determined by quantitative autoradiography. J. Neurosci. Res. 28:1991;331-342.
4. Balzan S., Ghione S., Pieraccini L., Biver P., Di Bartolo V. and Montali U. (1994) Endogenous digitalis-like factor from umbilical cord and ouabain: comparison of biochemical properties. In The Sodium Pump (eds Bamberg E. and Schoner W.), pp. 755-758. Steinkopff, Darmstadt.
5. Birks R.I. The role of sodium ions in the metabolism of acetylcholine. Can. J. Biochem. Physiol. 39:1963;2573-2597.
6. Di Bartolo V., Balzan S., Pieraccini L., Ghione S., Pegoraro S., Biver P., Revoltella R., Montali U. Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC. Life Sci. 57:1995;1417-1425.
7. Gaitonde B.B., Joglekar S.N. Mechanism of neurotoxicity of cardiotonic glycosides. Br. J. Pharmac. Chemother. 59:1977;223-229.
8. Garcia A.G., Kirpekar S.M. Release of noradrenaline from the cat spleen by sodium deprivation. Br. J. Pharmac. 47:1973;729-747.
9. Goto A., Yamada K., Yagi N., Yoshioka M., Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmac. Rev. 44:1992;377-399.
10. -10 M). Naunyn-Schmiedeberg's Arch. Pharmac. 296:1979;293-296.
11. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Harris D.W., Mandel F., Mathews W.R., Ludens J.H. Identification and characterization of a ouabain-like compound from human plasma. Proc. natn. Acad. Sci. U.S.A. 88:1991;6259-6263.
12. +) ATPase associated with essential hypertension. Nature. 300:1982;650-652.
13. +ATPase inhibition by a rat brain endogenous factor (II-E). Neurochem. Res. 23:1998;33-37.
14. Huang B.S., Leenen F.H. H. Brain ouabain, sodium, and arterial baroreflex in spontaneous hypertensive rats. Hypertension. 25(part 2):1995;814-817.
15. Kirpekar S.M., Prat J.C., Yamamoto H. Effects of metabolic inhibitors on norepinephrine release from the perfused spleen of the cat. J. Pharmac. exp. Ther. 172:1970;342-350.
16. Kunes J., Stolba P., Pohlova I., Jelinek J., Zicha J. The importance of endogenous digoxin-like factors in rats with various forms of experimental hypertension. Clin. exp. Hypert. A7:1985;707.
17. Leenen F.H. H., Harmsen E., Yu H. Dietary sodium and central vs. peripheral ouabain-like activity in Dahl salt-sensitive vs. salt-resistant rats. Am. J. Physiol. 267:1994;H1916-H1920.
18. Leenen F.H. H., Harmsen E., Yu H., Ou C. Effects of dietary sodium on central and peripheral ouabain-like activity in spontaneously hypertensive rats. Am. J. Physiol. 264:1993;H2051-H2055.
19. Leenen F.H. H., Huang B.S., Yu H., Yuan B. Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure. Circulation Res. 77:1995;993-1000.
20. Mathews W.R., DuCharme D.W., Hamlyn J.M., Harris D.W., Mandel F., Clark M.A., Ludens J.H. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension. 17:1991;930-935.
21. +-ATPase. Life Sci. 47:1990;1091-1098.
22. Paton W.D. M., Vizi E.S., Zar M.A. The mechanism of acetylcholine release from parasympathetic nerves. J. Physiol., Lond. 215:1971;819-848.
23. +-ATPase inhibitor and ouabain. Neurochem. Res. 22:1997;379-383.
24. +-ATPase and its regulation by catecholamines. In Neural Transmission, Learning and Memory (eds Caputto R. and Ajmone Marsand C.), pp. 147-158. Raven, New York.
25. +-ATPase regulators. Molec. Neurobiol. 6:1992;359-375.
26. +. Neurochem. Res. 18:1993;655-661.
27. Rodríguez de Lores Arnaiz G., Alberici M., De Robertis E. Ultrastructural and enzymic studies of cholinergic and non-cholinergic synaptic membranes isolated from brain cortex. J. Neurochem. 14:1967;215-225.
28. +-ATPase. Neurochem. Res. 11:1986;933-947.
29. +-ATPase. Life Sci. 42:1988;2683-2689.
30. Rodríguez de Lores Arnaiz G., Antonelli de Gómez de Lima M., Girardi E. Different properties of two brain fractions separated in Sephadex G-50 that modify synaptosomal ATPase activities. Neurochem. Res. 3:1988;229-235.
31. +-ATPase. Microsc. Electr. Biol. Cell. 15:1991;93-106.
32. +-ATPase inhibitors. Neurochem. Int. 27:1995;319-327.
33. +ATPase interaction with a brain endobain. J. Neurochem. 69(Suppl.):1997;S64D.
34. Schiebinger R.J., Cragoe E.J. Jr. Ouabain: a stimulator of atrial natriuretic peptide secretion and its mechanism of action. Circulation Res. 72:1993;1035-1043.
35. +-ATPase of nervous tissue. Neurochem. Int. 8:1986;449-476.
36. +-ATPase-specific inhibitor from pig urine. Eur. J. Biochem. 211:1993;317-327.
37. +-ATPase inhibitor from bovine adrenal. Biochemistry. 27:1988;4244-4253.
38. Trifaró J.M., Vitale M.L. Cytoskeleton dynamics during neurotransmitter release. Trends Neurosci. 16:1993;466-472.
39. Tymiak A.A., Norman J.A., Bolgar M., DiDonato G.C., Lee H., Parker W.L., Lo L.C., Berova N., Nakanishi K., Haber E., Haupert G.T. Jr. Physicochemical characterization of an ouabain isomer isolated from bovine hypothalamus. Proc. natn. Acad. Sci. U.S.A. 90:1993;8189-8193.
40. Umbriaco D., Garcia S., Beaulieu C., Descarriers L. Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus. 5:1995;605-620.
41. 2+)-activated ATPase, of acetylcholine release in cortical slices from rat brain. J. Physiol., Lond. 226:1972;95-117.
42. +-activated adenosine triphosphatase as a trigger in transmitter release. Neuroscience. 3:1978;367-384.
43. +-ATPase, its endogenous ligands and neurotransmitter release. Neurochem. Int. 20:1992;11-17.
44. Vizi E.S., Oberfrank F., Bernath S., Lichtstein D. Noradrenaline releasing effect of an ouabain-like compound on pulmonary artery. Neuropharmacology. 26:1987;1541-1544.
45. +-ATPase in nervous tissue. In Neuromethods, Enzymes (eds Boulton A. A., Baker G. B. and Wu P. H.), pp. 451-502. Humana, Clifton, NJ.